Tom Baruch
Managing Director @ Baruch Future Ventures
San Francisco, United States
Tom Baruch is a Series B investor at Baruch Future Ventures in San Francisco focused on Manufacturing and Biotechnology. Tom Baruch is the Founder and Managing Director at Baruch Future Ventures. He graduated with an Engineering degree from Rensselaer Polytechnic Institute.
- Total investments:
- 14
- Last investment:
- Lead investor:
- 21%
Last updated:
For AI agents: llms.txt
Industries Tom Baruch invests in
Stages Tom Baruch invests in
Countries Tom Baruch invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Manufacturing 3 (21%)
- Biotechnology 2 (14%)
- Nanotechnology 2 (14%)
- Renewable Energy 2 (14%)
- Advanced Materials 2 (14%)
Stage
- Series B 4 (29%)
- Seed 2 (14%)
- Series A 2 (14%)
- Series D 2 (14%)
- Series C 1 (7%)
Country
- United States 6 (43%)
- Canada 1 (7%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
LuxWall
|
LuxWall is a building materials manufacturer that innovates the design and production of vacuum-insulated glass. The company was founded in 2020 and is headquartered in Ypsilanti, Michigan, United States. | $51M / Series B / Oct 31, 2024 | |
Oneka Technologies
|
Traditional desalination is an expensive, unsustainable, inefficient, and polluting $20bn/yr market. It is essentially a process to transform fossil fuels into potable water. Our company harnesses wave power to produce fresh water with zero GHG, zero land, responsible brine using modular units for water-scarce regions in the world whilereducing their water costs by up to 75% in identified markets. Oneka has already demonstrated its technology in the ocean.The mission of Oneka is to make the oceans the most sustainable and affordable source of drinking water. | $4.5M / Seed / Jun 23, 2021 | |
Geltor
|
Biodesigned proteins for beauty, wellness and beyond. | $4.5M / Seed / Feb 01, 2016 | |
Solyndra
|
Solyndra is a manufacturer of cylindrical panels of CIGS thin-film solar cells based in Fremont, California.Solyndra designs and manufactures photovoltaic systems, comprised of panels and mounting hardware, for the commercial rooftop market. Solyndra employs high volume manufacturing based on proven technologies and processes to meet the needsof the global solar market. Using proprietary cylindrical modules and thin-film technology, Solyndra systems are designed to provide the lowest installed cost per system and the highest solar electrical energy output for typical low slope commercial rooftops. Founded in 2005 and headquartered in Fremont, California, Solyndra operates a state-of-the-art 300,000 square foot fully-automated manufacturing complex. | $175M / Private Equity / Jun 18, 2010 | |
Cnano Technology
|
Beijing Cnano Technology Co. Ltd. is dedicated to the production of carbon nanotubes and application of advanced energy that includes the application of lithium battery, conductive plastics, and mechanical structures. It is the Chinese branch of the Cnano Company. On the basis of acquiring the exclusive licensing of a patent from TsinghuaUniversity, in combination with its own internal technological innovation, Cnano Technology has developed a large-batch production technology of carbon nano-tubes. Headquartered in Santa Clara, California, USA, Cnano Technology has established advanced research and manufacturing facilities in Beijing, China. | $7M / Series B / Jan 01, 2010 | |
Intermolecular
|
Intermolecular provides high productivity combinatorial (HPC) technology products and services. The company offers Tempus HPC Platform, an integrated processing and informatics system that stimulates materials discovery, process development, and IC device integration for chipmakers, materials suppliers, and equipment manufacturers. It also offerswet workflow systems for self-assembly processing, electroless deposition, wet etching and stripping, cleaning, and surface preparation applications; ALD and PVD workflow systems; and HPC test chips. The company serves pharmaceutical, biotechnology, and energy industries. | $20M / Series D / Jan 08, 2009 | |
|
Solyndra
|
Solyndra is a manufacturer of cylindrical panels of CIGS thin-film solar cells based in Fremont, California.Solyndra designs and manufactures photovoltaic systems, comprised of panels and mounting hardware, for the commercial rooftop market. Solyndra employs high volume manufacturing based on proven technologies and processes to meet the needsof the global solar market. Using proprietary cylindrical modules and thin-film technology, Solyndra systems are designed to provide the lowest installed cost per system and the highest solar electrical energy output for typical low slope commercial rooftops. Founded in 2005 and headquartered in Fremont, California, Solyndra operates a state-of-the-art 300,000 square foot fully-automated manufacturing complex. | $220M / Series E / Dec 01, 2008 | |
|
Cnano Technology
|
Beijing Cnano Technology Co. Ltd. is dedicated to the production of carbon nanotubes and application of advanced energy that includes the application of lithium battery, conductive plastics, and mechanical structures. It is the Chinese branch of the Cnano Company. On the basis of acquiring the exclusive licensing of a patent from TsinghuaUniversity, in combination with its own internal technological innovation, Cnano Technology has developed a large-batch production technology of carbon nano-tubes. Headquartered in Santa Clara, California, USA, Cnano Technology has established advanced research and manufacturing facilities in Beijing, China. | $6M / Series A / Jul 01, 2007 | |
|
Intermolecular
|
Intermolecular provides high productivity combinatorial (HPC) technology products and services. The company offers Tempus HPC Platform, an integrated processing and informatics system that stimulates materials discovery, process development, and IC device integration for chipmakers, materials suppliers, and equipment manufacturers. It also offerswet workflow systems for self-assembly processing, electroless deposition, wet etching and stripping, cleaning, and surface preparation applications; ALD and PVD workflow systems; and HPC test chips. The company serves pharmaceutical, biotechnology, and energy industries. | $27.6M / Series C / Sep 20, 2006 | |
Codexis
|
Codexis, Inc. is an industrial biotechnology company that specializes in engineers enzymes for pharmaceutical and chemical production through biocatalysis. Codexis’ technologies enable scale-up and implementation of biocatalytic solutions to optimize process development, from research to manufacturing. There are currently over 50 pharmaceuticalfirms using Codexis’ technology, products and services in their manufacturing process development.Codexis creates its products by applying its CodeEvolver® directed evolution technology platform, which introduces genetic mutations into microorganisms.Codexis, Inc. began operations as an independent company in 2002, and became a publicly traded company in 2009. They are located in Redwood City, CA USA | Series D / Aug 14, 2006 | |
| See all 14 investments → | |||
Co-Investors
About Baruch Future Ventures
Baruch Future Ventures is a venture capital firm committed to investing in early-stage companies that prioritize climate-focused initiatives. The company also specializes in health care, diagnostic, therapeutic, air quality, efficient energy systems, food security, sustainable agriculture, water treatment, and conservation sectors.
Baruch Future Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Tom Baruch
Managing Director
|
|||
August Fern
Consultant
|
|||
Fabio Ficano
Investor
|
|||
Jason Holt
Partner
|
|||
Miranda May
Executive Assistant
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Tom Baruch invest in?
Tom Baruch invests primarily in Manufacturing, Biotechnology and Nanotechnology startups, most often at Series B and Seed stage. Most of the 14 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Tom Baruch?
Public channels for Tom Baruch include LinkedIn, the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Tom Baruch last invest?
The most recent investment recorded for Tom Baruch closed in Oct 2024. Shizune tracks 14 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
